Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Arcticzymes Tech | Oslo | Healthcare | Biotechnology & Medical Research | NOK 865.66M | 427.5x | -4.35 | NOK 16.95 | 4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.3% Upside | Upgrade to Pro+ | |
Thor Medical | Oslo | Healthcare | Biotechnology & Medical Research | NOK 830.04M | -14.4x | 1.11 | NOK 2.64 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lytix Biopharma AS | Oslo | Healthcare | Biotechnology & Medical Research | NOK 647.12M | NOK 9.48 | 12.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Nykode Therapeutics | Oslo | Healthcare | Biotechnology & Medical Research | NOK 645.91M | -2.1x | -0.06 | NOK 1.98 | 8.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SoftOx Solutions | Oslo | Healthcare | Biotechnology & Medical Research | NOK 173.86M | -3.8x | -0.04 | NOK 0.08 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Exact Therapeutics AS | Oslo | Healthcare | Biotechnology & Medical Research | NOK 163.22M | -2x | NOK 2.58 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Lifecare | Oslo | Healthcare | Biotechnology & Medical Research | NOK 106.53M | -1.3x | 0.04 | NOK 6.62 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PCI Biotech | Oslo | Healthcare | Biotechnology & Medical Research | NOK 61.22M | -3.3x | -0.2 | NOK 1.64 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Circio Holding | Oslo | Healthcare | Biotechnology & Medical Research | NOK 60.43M | 0.2x | 0.01 | NOK 0.61 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bergenbio | Oslo | Healthcare | Biotechnology & Medical Research | NOK 53.24M | -0.5x | -0.01 | NOK 1.36 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 40.7% Upside | Upgrade to Pro+ | |
Zelluna | Oslo | Healthcare | Biotechnology & Medical Research | NOK 37.42M | -0x | NOK 14.16 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |